Ping Tao Selected Research

valylleucine

8/2011

Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ping Tao Research Topics

Disease

9	Breast Neoplasms (Breast Cancer) 01/2019 - 03/2006
8	Neoplasms (Cancer) 01/2023 - 05/2005
7	Wounds and Injuries (Trauma) 02/2022 - 08/2012
4	Hypoxia (Hypoxemia) 01/2023 - 12/2017
4	Colitis 02/2022 - 12/2017
2	Poisoning 04/2024 - 01/2021
2	Inflammation (Inflammations) 01/2024 - 01/2018
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2023
2	Myocardial Infarction 01/2023 - 10/2019
1	Dementia (Dementias) 04/2024
1	Pressure Ulcer (Bedsore) 02/2024
1	Premature Obstetric Labor (Premature Labor) 01/2024
1	Leukemia 01/2024
1	Parkinson Disease (Parkinson's Disease) 01/2023
1	Cicatrix (Scar) 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Ulcerative Colitis 12/2021
1	Carbon Monoxide Poisoning (Poisoning, Carbon Monoxide) 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Cholangiocarcinoma 05/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Edema (Dropsy) 10/2019
1	Cardiac Edema 10/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2019
1	Necrosis 10/2019
1	Microscopic Colitis 11/2018
1	Overweight 04/2017
1	Acute Kidney Injury (Acute Renal Failure) 08/2012
1	Burns 08/2012
1	Communicable Diseases (Infectious Diseases) 08/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2007

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2010
3	Peptides (Polypeptides)IBA 01/2023 - 05/2005
3	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 08/2011 - 03/2006
2	Carbon MonoxideIBA 04/2024 - 01/2021
2	Indicators and Reagents (Reagents)IBA 01/2023 - 01/2013
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2018 - 12/2017
2	Dextrans (Dextran)FDA Link 01/2018 - 12/2017
2	IodoacetamideIBA 01/2018 - 12/2017
2	Interleukin-4 (Interleukin 4)IBA 01/2018 - 12/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 12/2017
2	Interleukin-10 (Interleukin 10)IBA 01/2018 - 12/2017
2	IsoflavonesIBA 01/2016 - 08/2011
2	Dichlorodiphenyldichloroethane (DDD)IBA 07/2006 - 03/2006
2	DDTIBA 07/2006 - 03/2006
1	Complement System Proteins (Complement)IBA 02/2024
1	Nicotine FDA Link 01/2024
1	Sirtuin 1IBA 01/2024
1	phorbolIBA 01/2024
1	Extracellular Matrix ProteinsIBA 01/2023
1	CollagenIBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 01/2023
1	Small Cytoplasmic RNAIBA 01/2023
1	N 30IBA 01/2023
1	Dextran SulfateIBA 02/2022
1	Adenosine Triphosphate (ATP)IBA 02/2022
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 02/2022
1	IsoenzymesIBA 02/2022
1	Glucose (Dextrose)FDA LinkGeneric 02/2022
1	HydrogenIBA 02/2022
1	notoginsenoside R2IBA 12/2021
1	Protein Kinase C-thetaIBA 12/2021
1	CytokinesIBA 12/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	LigandsIBA 05/2020
1	Immune Checkpoint ProteinsIBA 05/2020
1	Imatinib Mesylate (Gleevec)FDA Link 01/2020
1	Vascular Endothelial Growth Factor CIBA 10/2019
1	HydrogelsIBA 10/2019
1	Oral ContraceptivesIBA 01/2019
1	Proton Pump InhibitorsIBA 11/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	Ethanol (Ethyl Alcohol)IBA 12/2017
1	Phenobarbital (Luminal)FDA Link 04/2017
1	Insulin-Like Growth Factor Binding Protein 3IBA 01/2016
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2016
1	Insulin-Like PeptidesIBA 01/2016
1	histidylhistidine (His-His)IBA 05/2012
1	AminesIBA 05/2012
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 05/2012
1	leucylleucine (Leu-Leu)IBA 08/2011
1	valylvaline (Val-Val)IBA 08/2011
1	methionylmethionine (Met-Met)IBA 08/2011
1	valylleucineIBA 08/2011
1	Messenger RNA (mRNA)IBA 03/2010
1	Estrogens (Estrogen)FDA Link 09/2008
1	EnzymesIBA 09/2008
1	Tobacco Smoke Pollution (Passive Smoking)IBA 09/2008
1	MidkineIBA 08/2007

Therapy/Procedure

3	Transplantation 01/2023 - 08/2012
3	Therapeutics 01/2021 - 10/2019
1	Ligation 01/2023
1	Aftercare (After-Treatment) 01/2021
1	Cesarean Section (Caesarean Section) 01/2021
1	Length of Stay 01/2021
1	Intrauterine Devices (Intrauterine Device) 01/2019
1	Induced Abortion (Induced Abortions) 01/2019
1	Contraception (Birth Control) 01/2019
1	Polypharmacy 08/2012